RVL Pharmaceuticals

NASDAQ: OSMT · Real-Time Price · USD
1.11
-0.02 (-1.77%)
At close: Jan 19, 2022, 5:00 AM

RVL Pharmaceuticals Revenue

RVL Pharmaceuticals reported an annual revenue of $49.72M, reflecting a 184.1% growth. For the quarter ending June 30, 2023, RVL Pharmaceuticals generated $8.26M in revenue.
Revenue (ttm)
$49.72M
Revenue Growth
184.1%
Price / Sales Ratio
2.02
Revenue / Employee
$164.64K
Employees
302
Market Cap
110.18M

Revenue Chart

Revenue History

Fiscal Year End Revenue % Change
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.